end stage renal disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with maintenance hemodialysis (2) Patients with renal anemia, who are treated with rHuEPO and iron
Exclusion criteria
Exclusion criteria: Severe congestive heart failure Uncontrolled hypertension Malignancy Major surgery within the previous 6 months Active bleeding, need for erythrocyte transfusion within 12 weeks before the study Systemic inflammatory disease and/or C-reactive protein levels >3 mg/dL
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Death and its reason in five years. | — |
Countries
Japan
Contacts
Yokohama National University Center for Health Service Sciences